NCT00653848View on ClinicalTrials.gov

Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy

PHASE3UnknownINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions
Prostate Cancer
Interventions
DRUG

docetaxel

docetaxel 75 mg/square meter i.v. every third week, six cycles

Trial Locations (1)

Unknown

Jon R Iversen, Oslo

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Scandinavian Prostate Cancer Group

NETWORK

NCT00653848 - Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy | Biotech Hunter | Biotech Hunter